Skip to content

The Effect of Combined Lidocaine and Dexamethasone for Glottic Surface Anesthesia Following Anesthetic Induction on Postoperative Pharyngitis Incidence and Hemodynamic Status During Tracheal Intubation in Oral and Maxillofacial Surgery: A Prospective Three-Arm Randomized Controlled Trial

The Effect of Combined Lidocaine and Dexamethasone for Glottic Surface Anesthesia Following Anesthetic Induction on Postoperative Pharyngitis Incidence and Hemodynamic Status During Tracheal Intubation in Oral and Maxillofacial Surgery: A Prospective Three-Arm Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600120983
Enrollment
Unknown
Registered
2026-03-24
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Sore Throat after tracheal intubation in oral and maxillofacial surgery.

Interventions

Lidocaine group:Lidocaine Glottic Surface Anesthesia
Lidocaine combined with dexamethasone Group:Lidocaine Combined with Dexamethasone for Glottic Surface Anesthesia
Saline Group:Saline spray applied to the glottis

Sponsors

The Affiliated Stomatological Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Age 18–45 years; 2. Scheduled for impacted tooth extraction, with an estimated procedure duration of 1–2 hours; 3. Requires nasopharyngeal video laryngoscope-guided tracheal intubation; 4. Preoperative fasting requirements completed; 5. Consents to participate in this study and has signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Refusal to participate in this study; 2. Emergency surgery; 3. Pre-existing throat conditions: acute laryngitis, chronic bronchitis, asthma, or upper respiratory tract diseases that may cause throat pain, including pre-existing symptoms such as sore throat, cough, or hoarseness; 4. Patients with a confirmed preoperative diagnosis of diabetes; 5. Patients undergoing general anesthesia within the past three months; 6. Patients with known allergies to lidocaine or dexamethasone; 7. Severe hepatic or renal impairment: ALT > 3 times the upper limit of normal, creatinine > 1.5 times the upper limit of normal; 8. Pregnant or lactating women; 9.History of difficult intubation, Cormack-Lane classification >= Grade III, or requiring multiple intubation attempts; 10. Critically ill patients (ASA classification >= Grade IV); 11. Currently participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Incidence rate of postoperative sore throat;

Secondary

MeasureTime frame
Incidence of severe postoperative hypotension within 12 hours after surgery;Incidence of Hypertension During Anesthesia and Endotracheal Intubation;Postoperative nausea and vomiting 12 hours after surgery;Incidence of Hypotension During Anesthesia and Endotracheal Intubation;Postoperative 24-Hour Recovery Quality Score;Time for postoperative throat pain to subside;

Countries

China

Contacts

Public ContactSun Qiang

The Affiliated Stomatological Hospital of Nanjing Medical University

njsunq@sina.com+86 25 69593441

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 4, 2026